NUVB
USDNuvation Bio Inc. Class A Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$5.150
High
$5.190
Low
$3.920
Volume
6.20M
Company Fundamentals
Market Cap
1.7B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
7.11M
Exchange
NYQ
Currency
USD
52-Week Range
Related News
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.